J. Port

发表

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

S. Rafii, N. Altorki, D. Hicklin, 2005, Nature.

The lung microenvironment: an important regulator of tumour growth and metastasis

Nasser K. Altorki, Ashish Saxena, Vivek Mittal, 2018, Nature Reviews Cancer.

Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.

N. Altorki, J. Port, B. Stiles, 2011, The Annals of thoracic surgery.

Tobacco smoke induces CYP1B1 in the aerodigestive tract.

N. Altorki, L. Kopelovich, J. Port, 2004, Carcinogenesis.

Robotic Thymectomy: Learning Curve and Associated Perioperative Outcomes.

N. Altorki, J. Port, B. Stiles, 2017, Journal of laparoendoscopic & advanced surgical techniques. Part A.

Successful catheter-directed thrombolysis of a massive pulmonary embolism in a patient after recent pneumonectomy.

D. Madoff, J. Port, J. Horowitz, 2015, Clinical imaging.

CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.

G. Sica, N. Altorki, A. Saqi, 2009, The Journal of thoracic and cardiovascular surgery.

Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer.

N. Altorki, J. Port, R. Korst, 2004, The Annals of thoracic surgery.

The importance of lymph node dissection accompanying wedge resection for clinical stage IA lung cancer†

N. Altorki, J. Port, B. Stiles, 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Sternal Resections: New Materials for Reconstruction

N. Altorki, J. Port, M. Kamel, 2015, Current Surgery Reports.

Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: results of a phase II trial.

M. Pasmantier, J. Port, R. Korst, 2003, The Journal of thoracic and cardiovascular surgery.

Esophagectomy and Reconstruction

N. Altorki, J. Port, M. Kent, 2003 .

Never smokers with resected lung cancer: different demographics, similar survival†

N. Altorki, J. Port, B. Stiles, 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Electromagnetic Navigational Bronchoscopy

J. Port, S. Harrison, 2013, Seminars in Interventional Radiology.

Tumor size predicts survival within stage IA non-small cell lung cancer.

D. Libby, M. Pasmantier, N. Altorki, 2003, Chest.

Lobectomy in octogenarians with non-small cell lung cancer: ramifications of increasing life expectancy and the benefits of minimally invasive surgery.

N. Altorki, J. Port, B. Stiles, 2011, The Annals of thoracic surgery.

Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery: Effects of Cumulative Institutional Experience on Adequacy of Lymphadenectomy.

N. Altorki, J. Port, B. Stiles, 2016, The Annals of thoracic surgery.

Video-Assisted Thoracoscopic Surgery Is a Safe and Effective Alternative to Thoracotomy for Anatomical Segmentectomy in Patients With Clinical Stage I Non-Small Cell Lung Cancer.

N. Altorki, J. Port, B. Stiles, 2016, The Annals of thoracic surgery.

Oncologic considerations in the elderly

J. Port, M. Kamel, 2017, Current opinion in anaesthesiology.

Ratio of positron emission tomography uptake to tumor size in surgically resected non-small cell lung cancer.

N. Altorki, J. Port, T. McGraw, 2013, The Annals of thoracic surgery.

Video-Assisted Thoracoscopic Lobectomy Is the Preferred Approach Following Induction Chemotherapy.

N. Altorki, J. Port, B. Stiles, 2017, Journal of laparoendoscopic & advanced surgical techniques. Part A.

Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database.

N. Altorki, D. Harpole, J. Port, 2010, The Journal of thoracic and cardiovascular surgery.

Lung-conserving treatment of a pulmonary oligometastasis with a wedge resection and 131Cs brachytherapy.

J. Port, B. Parashar, A. Wernicke, 2013, Brachytherapy.

Lung cancer patients have the highest malignancy-associated suicide rate in USA: a population-based analysis

N. Altorki, J. Port, Ihab Eldessouki, 2018, Ecancermedicalscience.

National trends and perioperative outcomes of robotic oesophagectomy following induction chemoradiation therapy: a National Cancer Database propensity-matched analysis.

N. Altorki, J. Port, B. Stiles, 2020, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Celecoxib , a Select i ve Cyc lo-Oxygenase-2 Inhibi tor , Enhances the Response to Preoperat i ve Pacl i taxe l and Carboplat in in Early-Stage Non – Smal l-Cel l Lung Cancer

D. Yankelevitz, D. Libby, M. Pasmantier, 2003 .

Multilobulated thymoma with an acute angle: a new predictor of lung invasion

J. Port, J. Gruden, G. Askin, 2019, European Radiology.

Accuracy of surveillance computed tomography in detecting recurrent or new primary lung cancer in patients with completely resected lung cancer.

N. Altorki, J. Port, R. Korst, 2006, The Annals of thoracic surgery.

Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer.

N. Altorki, J. Port, B. Stiles, 2017, The Annals of thoracic surgery.

Predictors of Disease-free Survival and Recurrence in Patients with Resected Bronchial Carcinoid Tumors

N. Altorki, J. Port, B. Stiles, 2015, Thoracic and Cardiovascular Surgeon.

PAX-5 expression in pulmonary neuroendocrine neoplasms: its usefulness in surgical and fine-needle aspiration biopsy specimens.

G. Sica, A. Saqi, M. Vazquez, 2008, American journal of clinical pathology.

Sternal Reconstruction Using Customized 3D-Printed Titanium Implants.

Nasser Altorki, N. Altorki, J. Port, 2019, The Annals of thoracic surgery.

Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens

N. Narula, J. Port, R. Hoda, 2017, Cancer cytopathology.

Chemotherapy Induces the Expression of Cyclooxygenase-2 in Non–Small Cell Lung Cancer

H. Thaler, N. Altorki, J. Port, 2005, Clinical Cancer Research.

Incidence and Prognostic Significance of Carcinoid Lymph Node Metastases.

N. Altorki, J. Port, B. Stiles, 2018, The Annals of thoracic surgery.

Buthionine sulfoximine pretreatment potentiates the effect of isolated lung perfusion with doxorubicin.

M. Burt, J. Port, S. Hochwald, 1995, The Annals of thoracic surgery.

Complete metabolic response is not uniformly predictive of complete pathologic response after induction therapy for esophageal cancer.

N. Altorki, J. Port, B. Stiles, 2013, The Annals of thoracic surgery.

Technical and safety performance of CT-guided percutaneous microwave ablation for lung tumors: an ablate and resect study

T. Vogl, J. Port, D. Dupuy, 2021, Journal of thoracic disease.

Intrathoracic manifestations of cervical anastomotic leaks after transthoracic esophagectomy for carcinoma.

N. Altorki, J. Port, R. Korst, 2005, The Annals of thoracic surgery.

Extended resection of sarcomas involving the mediastinum: a 15-year experience†.

N. Altorki, J. Port, B. Stiles, 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Neoadjuvant Therapy for Locally Advanced Esophageal Cancer Should Be Targeted to Tumor Histology.

N. Altorki, J. Port, B. Stiles, 2019, The Annals of thoracic surgery.

Surgical resection for residual N2 disease after induction chemotherapy.

N. Altorki, J. Port, R. Korst, 2005, The Annals of thoracic surgery.

Staple line thickening after sublobar resection: reaction or recurrence?

N. Altorki, J. Port, B. Stiles, 2020, The Annals of thoracic surgery.

Predictors of Pleural Implants in Patients With Thymic Tumors.

N. Altorki, J. Port, B. Stiles, 2016, The Annals of thoracic surgery.

Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial.

N. Sanfilippo, O. Elemento, A. Borczuk, 2021, The Lancet. Oncology.

Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer.

D. Yankelevitz, D. Libby, M. Pasmantier, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition.

S. Rafii, Helen Sadik, P. Argani, 2012, Cancer research.

Thymoma: a multivariate analysis of factors predicting survival.

V. Rusch, P. McCormack, M. Bains, 1995, The Annals of thoracic surgery.

Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of Postoperative Disease Recurrence in Esophageal Cancer

A. Neugut, N. Altorki, J. Port, 2011, Annals of Surgical Oncology.

Thoracic esophageal perforations: a decade of experience.

N. Altorki, J. Port, R. Korst, 2003, The Annals of thoracic surgery.

Preoperative Taxane-Based Chemotherapy and Celecoxib for Carcinoma of the Esophagus and Gastroesophageal Junction: Results of a Phase 2 Trial

N. Altorki, J. Port, D. Schrump, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer.

N. Altorki, J. Port, P. Christos, 2010, The Journal of thoracic and cardiovascular surgery.

Multicenter, randomized phase II study of neoadjuvant pembrolizumab plus chemotherapy and chemoradiotherapy in esophageal adenocarcinoma (EAC).

N. Sanfilippo, R. Yantiss, N. Altorki, 2021 .

The lung microenvironment: an important regulator of tumour growth and metastasis

N. Altorki, J. Port, A. Saxena, 2018, Nature Reviews Cancer.

Pulmonary artery perfusion of doxorubicin with blood flow occlusion: pharmacokinetics and treatment in a metastatic sarcoma model.

M. Burt, J. Port, D. Blumberg, 1995, The Annals of thoracic surgery.

Carcinoid tumor nested within a bronchogenic cyst.

N. Altorki, J. Port, Paul C. Lee, 2008, The Journal of thoracic and cardiovascular surgery.

T1N0 oesophageal cancer: patterns of care and outcomes over 25 years†

N. Altorki, J. Port, B. Stiles, 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Surgical management of chylothorax.

N. Altorki, J. Port, S. Paul, 2009, The Thoracic and cardiovascular surgeon.

TNM stage is the most important determinant of survival in metachronous lung cancer.

N. Altorki, J. Port, B. Stiles, 2009, The Annals of thoracic surgery.

Locally advanced esophageal cancer: What becomes of 5-year survivors?

N. Altorki, J. Port, P. Christos, 2016, The Journal of thoracic and cardiovascular surgery.

Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus

N. Altorki, J. Port, M. Kent, 2002, Annals of surgery.

Hernia of Morgagni: case report.

N. Altorki, J. Port, D. Líška, 2008, Journal of Thoracic and Cardiovascular Surgery.

Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy.

N. Altorki, J. Port, B. Stiles, 2013, The Annals of thoracic surgery.

Giant cavernous hemangioma of the distal esophagus treated with esophagectomy.

N. Altorki, J. Port, R. Korst, 2007, The Journal of thoracic and cardiovascular surgery.

A simple solution for management of the postpneumonectomy empyema cavity.

N. Altorki, J. Port, R. Korst, 2004, The Annals of thoracic surgery.

Partial Upper Sternotomy for Anterosuperior Mediastinal Surgery: An Institutional Experience

N. Altorki, J. Port, B. Stiles, 2009, Annals of Surgical Oncology.

Gastropericardial fistula: a late complication of esophageal reconstruction.

N. Altorki, J. Port, B. Stiles, 2012, The Annals of thoracic surgery.

Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors.

G. Sica, A. Saqi, M. Vazquez, 2009, Archives of pathology & laboratory medicine.

Sensitivity and specificity of fine needle aspiration for the diagnosis of mediastinal lesions.

N. Altorki, J. Koizumi, A. Moreira, 2019, Annals of diagnostic pathology.

Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma.

M. Mazumdar, N. Altorki, J. Port, 2007, The Annals of thoracic surgery.

A Novel Platform for Proteomic Analysis of Proximal Source Pulmonary Venous Blood Identifies Potential Biomarkers for Non-Small Cell Lung Cancer (NSCLC)

N. Altorki, J. Port, R. Sordella, 2014 .

Surgery for thymoma.

R. Ginsberg, J. Port, Jeffrey L. Port, 2001, Chest surgery clinics of North America.

Revised technique of isolated lung perfusion in the rat.

M. Burt, J. Port, S. Hochwald, 1995, The Annals of thoracic surgery.

Isolated lung perfusion with FUDR is an effective treatment for colorectal adenocarcinoma lung metastases in rats.

M. Burt, J. Port, J. Ellis, 1995, The Annals of thoracic surgery.

Cigarette Smoking and Risk of Lung Metastasis from Esophageal Cancer

A. Neugut, N. Altorki, J. Port, 2008, Cancer Epidemiology Biomarkers & Prevention.

Isolated lung perfusion with FUDR in the rat: pharmacokinetics and survival.

M. Burt, J. Port, J. Ellis, 1996, The Annals of thoracic surgery.

Proliferative myositis: a rare pseudosarcoma of the chest wall.

N. Altorki, D. Flieder, J. Port, 2002, The Annals of thoracic surgery.

Total Number of Resected Lymph Nodes Predicts Survival in Esophageal Cancer

M. Mazumdar, N. Altorki, J. Port, 2008, Annals of surgery.

Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma.

N. Altorki, Yaniv Kerem, J. Port, 2006, The Annals of thoracic surgery.

Comparative analysis of diaphragmatic hernia repair outcomes using the nationwide inpatient sample database.

N. Altorki, J. Port, A. Sedrakyan, 2012, Archives of surgery.

Kaplan et al. reply

S. Rafii, N. Altorki, D. Hicklin, 2009, Nature.

PS01.42: Predictors of Incomplete Esophageal Cancer Resection: Questionable Role of Preoperative Therapy: Topic: Surgery

N. Altorki, J. Port, B. Stiles, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

PS01.45: Intraoperative Blood Loss is an Independent Predictor of Poor Disease Free Survival for Patients Undergoing VATS Lobectomy for Lung Cancer: Topic: Surgery

Mohamed S. Kamel, N. Altorki, J. Port, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.

N. Altorki, J. Port, B. Stiles, 2009, The Annals of thoracic surgery.

Depletion of high energy phosphate compouds in the tumor-bearing state and reversal after tumor resection.

M. Burt, J. Port, D. Blumberg, 1996, Surgery.

Multifocal Neoplasia and Nodal Metastases in T1 Esophageal Carcinoma: Implications for Endoscopic Treatment

M. Mazumdar, N. Altorki, J. Port, 2008, Annals of surgery.

Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report

G. Giaccone, N. Altorki, J. Port, 2021, Clinical Lung Cancer.

Resection of a symptomatic pericardial cyst using the computer-enhanced da Vinci Surgical System.

N. Altorki, J. Port, R. Korst, 2003, The Annals of thoracic surgery.

Surgical resection for lung cancer in the octogenarian.

N. Altorki, J. Port, R. Korst, 2004, Chest.

Sublobar resection for node-negative lung cancer 2-5 cm in size.

N. Altorki, J. Port, B. Stiles, 2019, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer ≤2 cm.

N. Altorki, J. Port, B. Stiles, 2019, The Journal of thoracic and cardiovascular surgery.

Point: Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: the problem of understaging.

Nasser K. Altorki, N. Altorki, J. Port, 2009, The Journal of thoracic and cardiovascular surgery.

Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer.

N. Altorki, J. Port, R. Korst, 2007, The Annals of thoracic surgery.

Predictors of Survival After Treatment of Oligometastases After Esophagectomy.

N. Altorki, J. Port, B. Stiles, 2017, The Annals of thoracic surgery.

Definitive therapy for isolated esophageal metastases prolongs survival.

N. Altorki, J. Port, B. Stiles, 2012, The Annals of thoracic surgery.

PL03.06 Lobar or Sub-lobar Resection for Peripheral Clinical Stage IA = 2 cm Non-small Cell Lung Cancer (NSCLC): Results From an International Randomized Phase III Trial (CALGB 140503 [Alliance])

D. Wigle, D. Kozono, T. Stinchcombe, 2022, Journal of Thoracic Oncology.

Survival of patients with clinical stage IIIA non-small cell lung cancer after induction therapy: age, mediastinal downstaging, and extent of pulmonary resection as independent predictors.

N. Altorki, J. Port, B. Stiles, 2011, The Journal of thoracic and cardiovascular surgery.

Surgical resection after neoadjuvant durvalumab and radiation is feasible and safe in non-small cell lung cancer: Results from a randomized trial.

N. Altorki, J. Port, B. Stiles, 2022, The Journal of thoracic and cardiovascular surgery.

Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.

N. Altorki, H. Pass, D. Kozono, 2023, The New England journal of medicine.

Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model.

N. Altorki, J. Port, R. Korst, 2005, The Annals of thoracic surgery.

National Analysis of Short-Term Outcomes After Pulmonary Resections on Cardiopulmonary Bypass.

N. Altorki, J. Port, Paul C. Lee, 2015, The Annals of thoracic surgery.

Current state of imaging for lung cancer staging.

N. Altorki, J. Port, M. Kent, 2004, Thoracic surgery clinics.

Tumor size is a determinant of stage distribution in t1 non-small cell lung cancer.

N. Altorki, D. Flieder, J. Port, 2005, Chest.

Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy.

N. Altorki, J. Port, B. Stiles, 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Role of wedge resection in bronchial carcinoid (BC) tumors: SEER database analysis.

N. Altorki, N. Narula, J. Port, 2019, Journal of thoracic disease.

Sublobar resection is comparable to lobectomy for screen-detected lung cancer.

N. Altorki, J. Port, B. Stiles, 2021, The Journal of thoracic and cardiovascular surgery.

Thoracic Surgery in the Elderly

J. Port, P. Heerdt, M. D. Castillo, 2011 .

Outcomes of Unresected Ground-Glass Nodules with Cytology Suspicious for Adenocarcinoma

D. Libby, N. Altorki, J. Port, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Surgical resection for multifocal (T4) non-small cell lung cancer: is the T4 designation valid?

N. Altorki, Yaniv Kerem, J. Port, 2007, The Annals of thoracic surgery.

Cumulative radiation dose from medical imaging procedures in patients undergoing resection for lung cancer.

D. Yankelevitz, C. Towe, N. Altorki, 2011, The Annals of thoracic surgery.

Safety of lung cancer surgery during COVID-19 in a pandemic epicenter

N. Altorki, J. Port, B. Stiles, 2022, The Journal of Thoracic and Cardiovascular Surgery.

Pulmonary sarcomatoid carcinoma: an analysis of a rare cancer from the Surveillance, Epidemiology, and End Results database†

N. Altorki, N. Narula, J. Port, 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

The emerging technique of electromagnetic navigation bronchoscopy‐guided fine‐needle aspiration of peripheral lung lesions: Promising results in 50 lesions

J. Port, R. Hoda, Florence L Loo, 2014, Cancer cytopathology.

Clinical predictors of early cancer-related mortality following neoadjuvant therapy and oesophagectomy.

N. Altorki, J. Port, B. Stiles, 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less.

N. Altorki, J. Port, R. Korst, 2005, The Journal of thoracic and cardiovascular surgery.

Prevalence and outcomes of anatomic lung resection for hemoptysis: an analysis of the nationwide inpatient sample database.

N. Altorki, J. Port, B. Stiles, 2013, The Annals of thoracic surgery.

Consequences of Refusing Surgery for Esophageal Cancer: A National Cancer Database Analysis.

N. Altorki, J. Port, B. Stiles, 2018, The Annals of thoracic surgery.

Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma.

N. Altorki, J. Port, P. Christos, 2011, The Journal of thoracic and cardiovascular surgery.

Outcomes after lobectomy using thoracoscopy vs thoracotomy: a comparative effectiveness analysis utilizing the Nationwide Inpatient Sample database.

N. Altorki, J. Port, B. Stiles, 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Do the surgical results in the National Lung Screening Trial reflect modern thoracic surgical practice?

N. Altorki, J. Port, B. Stiles, 2019, The Journal of thoracic and cardiovascular surgery.

Robotic Thymectomy Is Feasible for Large Thymomas: A Propensity-Matched Comparison.

N. Altorki, J. Port, B. Stiles, 2017, The Annals of thoracic surgery.

PS01.46: Robotic Thymectomy: Early Stage Thymoma and Non‐Tumor Benign Lesions has Comparable Perioperative Outcomes: Topic: Surgery

N. Altorki, J. Port, B. Stiles, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Extended Lymphadenectomy Improves Survival After Induction Chemoradiation for Esophageal Cancer

N. Altorki, J. Port, B. Stiles, 2021, Annals of surgery.

Ten-Year Survival and Recurrence Patterns After Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus

N. Altorki, J. Port, A. Nasar, 2022, Annals of surgery.

Outcomes Following Surgical Resection of Early-Stage Lung Adenocarcinomas with EGFR mutations.

N. Altorki, J. Port, B. Stiles, 2021, The Annals of thoracic surgery.

Segmentectomy Is Equivalent to Lobectomy in Hypermetabolic Clinical Stage IA Lung Adenocarcinomas.

N. Altorki, J. Port, B. Stiles, 2019, The Annals of thoracic surgery.

Surgical Treatment at an Academic Medical Center is Associated with Statistically Insignificant Lung Cancer Survival Outcome Differences Related to ZIP Code

N. Altorki, J. Port, B. Stiles, 2023, World Journal of Surgery.

Surveillance computed tomography after complete resection for non-small cell lung cancer: results and costs.

N. Altorki, J. Port, R. Korst, 2005, The Journal of thoracic and cardiovascular surgery.

Treatment of cT3N1M0/IIIA non-small cell lung cancer and the risk of underuse of surgery.

N. Altorki, J. Port, B. Stiles, 2020, The Journal of thoracic and cardiovascular surgery.

A propensity-matched analysis of wedge resection and stereotactic body radiotherapy for early stage lung cancer.

N. Altorki, J. Port, B. Stiles, 2014, The Annals of thoracic surgery.

Radiographic and Clinical Characterization of False Negative Results from CT-Guided Needle Biopsies of Lung Nodules

C. Henschke, D. Yankelevitz, D. Libby, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Long-term survival and recurrence in patients with resected non-small cell lung cancer 1 cm or less in size.

N. Altorki, Yaniv Kerem, J. Port, 2006, The Journal of thoracic and cardiovascular surgery.

Perioperative Outcomes after Lung Resection in Obese Patients

N. Altorki, J. Port, B. Stiles, 2014, Thoracic and Cardiovascular Surgeon.

Outcomes of lobectomy in patients with severely compromised lung function (predicted postoperative diffusing capacity of the lung for carbon monoxide % ≤ 40%).

N. Altorki, J. Port, B. Stiles, 2013, Annals of the American Thoracic Society.

Early lung cancer detection and treatment strategies.

N. Altorki, J. Port, M. Kent, 2002, Surgical oncology.

Prevalence, outcomes, and a risk-benefit analysis of diaphragmatic hernia admissions: an examination of the National Inpatient Sample database.

N. Altorki, J. Port, B. Stiles, 2011, The Journal of thoracic and cardiovascular surgery.

Incidence and Factors Associated With Hospital Readmission After Pulmonary Lobectomy.

Licia K. Gaber-Baylis, R. Zabih, N. Altorki, 2016, The Annals of thoracic surgery.

P2.04-92 Neoadjuvant Durvalumab With or Without Sub-Ablative Stereotactic Radiotherapy (SBRT) in Patients with Resectable NSCLC (NCT02904954)

N. Sanfilippo, A. Borczuk, N. Altorki, 2019, Journal of Thoracic Oncology.

Predictors of cervical and recurrent laryngeal lymph node metastases from esophageal cancer.

N. Altorki, J. Port, P. Christos, 2010, The Annals of thoracic surgery.

Surgery is the Optimum Local Therapeutic Modality for Second Primary Lung Cancer.

N. Altorki, J. Port, M. Kamel, 2016, Seminars in thoracic and cardiovascular surgery.

Extent of Resection Influences Survival in Early-Stage Lung Cancer with Occult Nodal Disease.

N. Altorki, J. Port, A. Nasar, 2022, The Annals of thoracic surgery.

P37.04 EGFR Mutations in US Hispanics with Lung Adenocarcinoma are Common and Portend a Worse Prognosis

N. Altorki, J. Port, B. Stiles, 2021 .

Outcomes of Unresected Ground-Glass Nodules with Cytology Suspicious for Adenocarcinoma

D. Libby, N. Altorki, J. Port, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Management and Outcomes of Patients on Preoperative Plavix (Clopidogrel) Undergoing General Thoracic Surgery

N. Altorki, J. Port, B. Stiles, 2012, Thoracic and Cardiovascular Surgeon.

Perioperative growth hormone improves wound healing and immunologic function in rats receiving adriamycin.

M. Burt, J. Port, D. Blumberg, 1995, The Journal of surgical research.

Total Number of Resected Lymph Nodes Predicts Survival in Esophageal Cancer

M. Mazumdar, N. Altorki, J. Port, 2008, Annals of surgery.

Lung-conserving treatment of a pulmonary oligometastasis with a wedge resection and 131Cs brachytherapy.

J. Port, B. Parashar, D. Gupta, 2013, Brachytherapy.

Predictors of Disease-free Survival and Recurrence in Patients with Resected Bronchial Carcinoid Tumors

N. Altorki, J. Port, B. Stiles, 2015, Thoracic and Cardiovascular Surgeon.

Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for patients undergoing resection for primary non-small cell lung cancer.

N. Altorki, J. Port, B. Stiles, 2015, The Journal of thoracic and cardiovascular surgery.

Outcomes after lobectomy using thoracoscopy vs thoracotomy: a comparative effectiveness analysis utilizing the Nationwide Inpatient Sample database.

N. Altorki, J. Port, B. Stiles, 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.

G. Sica, N. Altorki, A. Saqi, 2009, Journal of Thoracic and Cardiovascular Surgery.